Resultados globales: 9 registros encontrados en 0.02 segundos.
Artículos, Encontrados 9 registros
Artículos Encontrados 9 registros  
1.
11 p, 618.2 KB Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities : Laboratory tools for an early and differential diagnosis / Moreno-Castaño, Ana Belén (Hospital Clínic i Provincial de Barcelona) ; Fernández, Sara (Hospital Clínic i Provincial de Barcelona) ; Ventosa, Helena (Hospital Clínic i Provincial de Barcelona) ; Palomo, Marta (Hospital Clínic i Provincial de Barcelona) ; Martinez-Sanchez, Julia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ramos, Alex (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ortiz-Maldonado, Valentín (Hospital Clínic i Provincial de Barcelona) ; Delgado, Julio (Hospital Clínic i Provincial de Barcelona) ; Fernández De Larrea, Carlos (Hospital Clínic i Provincial de Barcelona) ; Urbano-Ispizua, Alvaro (Hospital Clínic i Provincial de Barcelona) ; Penack, Olaf (Charité Universitätsmedizin Berlin, Germany) ; Nicolás, J.M. (Hospital Clínic i Provincial de Barcelona) ; Téllez, Adrian (Hospital Clínic i Provincial de Barcelona) ; Escolar, Gines (Hospital Clínic i Provincial de Barcelona) ; Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Fernández-Avilés, Francesc (Hospital Clínic i Provincial de Barcelona) ; Castro Rebollo, Pedro (Hospital Clínic i Provincial de Barcelona) ; Diaz-Ricart, Maribel (Hospital Clínic i Provincial de Barcelona)
Background Chimeric antigen receptor (CAR)-T cell-based immunotherapy constitutes a revolutionary advance for treatment of relapsed/refractory hematological malignancies. Nevertheless, cytokine release and immune effector cell-associated neurotoxicity syndromes are life-threatening toxicities in which the endothelium could be a pathophysiological substrate. [...]
2023 - 10.1136/jitc-2022-006365
Journal for immunotherapy of cancer, Vol. 11 Núm. 4 (april 2023)  
2.
14 p, 308.2 KB At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation : A Unicentric, Safe, and Feasible Program / Ruiz-Boy, Sonia (Hospital Clínic i Provincial de Barcelona) ; Pedraza, Alexandra (Hospital Clínic i Provincial de Barcelona) ; Prat, Marta (Hospital Clínic i Provincial de Barcelona) ; Salas, María Queralt (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Carcelero, Ester (Hospital Clínic i Provincial de Barcelona) ; Riu-Viladoms, G (Hospital Clínic i Provincial de Barcelona) ; Suárez-Lledó Grande, María (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Monge-Escartín, Inés (Hospital Clínic i Provincial de Barcelona) ; Rodríguez-Lobato, Luís Gerardo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Martínez-Roca, Alexandra (Hospital Clínic i Provincial de Barcelona) ; Rovira Argelagués, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Martínez, Carmen (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gallego, Cristina (Hospital Clínic i Provincial de Barcelona) ; Urbano-Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Sánchez, Juan (Hospital Clínic i Provincial de Barcelona) ; Marcos, María Ángeles (Hospital Clínic i Provincial de Barcelona) ; Fernández-Avilés, Francesc (Hospital Clínic i Provincial de Barcelona)
Cytomegalovirus (CMV) infection is a relevant cause of morbimortality in patients receiving allogeneic stem cell transplantation (allo-HCT). Foscarnet (FCN) is an effective drug against CMV administered intravenously and usually on an inpatient basis. [...]
2023 - 10.3390/ph16121741
Pharmaceuticals, Vol. 16 Núm. 12 (december 2023) , p. 1741  
3.
10 p, 3.0 MB Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era / Salas, María Queralt (Hospital Clínic i Provincial de Barcelona) ; Rodríguez Lobato, Luis Gerardo (Hospital Clínic i Provincial de Barcelona) ; Charry, Paola (Hospital Clínic i Provincial de Barcelona) ; Suárez-Lledó, Maria (Hospital Clínic i Provincial de Barcelona) ; Pedraza, Alexandra (Hospital Clínic i Provincial de Barcelona) ; Solano, María Teresa (Hospital Clínic i Provincial de Barcelona) ; Arcarons, Jordi (Hospital Clínic i Provincial de Barcelona) ; Cid, Joan (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Lozano, Miquel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rosiñol, Laura (Hospital Clínic i Provincial de Barcelona) ; Esteve, Jordi (Hospital Clínic i Provincial de Barcelona) ; Carreras, Enric (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Fernandez Aviles, Francesc (Hospital Clínic i Provincial de Barcelona) ; Martínez, Carmen (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rovira Tarrats, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
We investigated the predictive capacity of six prognostic indices [Karnofsky Performance Status (KPS), Hematopoietic Cell Transplant-Specific Comorbidity Index (HCT-CI), Disease Risk Index (DRI), European Bone Marrow Transplantation (EBMT) and Revised Pre-Transplantation Assessment of Mortality (rPAM) Scores and Endothelial Activation and Stress Index (EASIX)] in 205 adults undergoing post-transplant cyclophosphamide (PTCy)-based allo-HCT. [...]
2023 - 10.1016/j.htct.2023.07.008
Hematology, Transfusion and Cell Therapy, 2023  
4.
7 p, 1.0 MB Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation : Experience of the Spanish Group of Hematopoietic Stem Cell Transplant / Bento, Leyre (Instituto de Investigación Sanitaria Islas Baleares) ; Bastida, José María (Hospital Universitario de Salamanca) ; Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ; García-Torres, Estefania (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ; Rivera, Daniel (Hospital Universitario de Salamanca) ; Bosch-Vilaseca, Anna (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; De Miguel, Carlos (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Martínez-Muñoz, María Esther (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Fernandez Aviles, Francesc (Hospital Clínic i Provincial de Barcelona) ; Roldán Galvan, Elisa (Hospital Universitari Vall d'Hebron) ; Chinea, Anabelle (Hospital Universitario Ramón y Cajal (Madrid)) ; Yáñez, Lucrecia (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Zudaire, Teresa (Complejo Hospitalario de Navarra) ; Vaz, Carlos Pinho (Instituto Português de Oncologia) ; Espigado, Ildefonso (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; López, Javier (Hospital Universitario Ramón y Cajal (Madrid)) ; Valcárcel, David (Hospital Universitari Vall d'Hebron) ; Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Cabrera, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Herrera, Concepción (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ; González-Porras, José Ramón (Hospital Universitario de Salamanca) ; Gutiérrez, Antonio (Instituto de Investigación Sanitaria Islas Baleares) ; Solano, Carlos (Hospital Clínic Universitari (València)) ; Sampol, Antonia (Instituto de Investigación Sanitaria Islas Baleares) ; Universitat Autònoma de Barcelona
Persistent thrombocytopenia is a common complication after allogeneic hematopoietic stem cell transplantation (allo-SCT). Romiplostim and eltrombopag are the currently available thrombopoietin receptor agonists (TPO-RAs), and some studies with very small numbers of cases have reported their potential efficacy in the allo-SCT setting. [...]
2019 - 10.1016/j.bbmt.2019.05.023
Biology of blood and marrow transplantation, Vol. 25 Núm. 9 (september 2019) , p. 1825-1831  
5.
5 p, 470.9 KB Spanish Cell Therapy Network (TerCel) : 15 years of successful collaborative translational research / Sánchez-Guijo, Fermín (Universidad de Salamanca) ; García-Olmo, Damián (Universidad Autónoma de Madrid) ; Prósper, Felipe (Universidad de Navarra) ; Martínez, Salvador (Instituto de Neurociencias UMH-CSIC) ; Zapata, Agustín (Universidad Complutense de Madrid) ; Fernandez Aviles, Francesc (IiSGM-Hospital General Universitario Gregorio Marañón) ; Toledo-Aral, Juan José (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Torres, Miguel (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; Fariñas, Isabel (Universitat de València) ; Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ; Labandeira-García, José Luis (Universidade de Santiago de Compostela) ; García-Sancho, Javier (Universidad de Valladolid) ; Moraleda, José M. (Universidad de Murcia) ; Universitat Autònoma de Barcelona
In the current article we summarize the 15-year experience of the Spanish Cell Therapy Network (TerCel), a successful collaborative public initiative funded by the Spanish government for the support of nationwide translational research in this important area. [...]
2020 - 10.1016/j.jcyt.2019.11.001
Cytotherapy, Vol. 22 Núm. 1 (january 2020) , p. 1-5  
6.
10 p, 1.0 MB Case report : Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders / Margarit-Soler, Adriana (Hospital Sant Joan de Déu (Manresa)) ; Deyà-Martínez, Ángela (Hospital Clínic i Provincial de Barcelona) ; Canizales, Juan Torres (Hospital Clínic i Provincial de Barcelona) ; Vlagea, Alexandru (Hospital Clínic i Provincial de Barcelona) ; García-García, Ana (Hospital Clínic i Provincial de Barcelona) ; Marsal, Júlia (Hospital Sant Joan de Déu (Manresa)) ; Trabazo del Castillo, María (Hospital Sant Joan de Déu (Manresa)) ; Planas, Sílvia (Hospital Sant Joan de Déu (Manresa)) ; Simó, Sílvia (Hospital Sant Joan de Déu (Manresa)) ; Esteve-Sole, Ana (Hospital Clínic i Provincial de Barcelona) ; Suárez-Lledó Grande, María (Hospital Clínic i Provincial de Barcelona) ; Badell Serra, Isabel (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Rovira Tarrats, Montserrat (Hospital Clínic i Provincial de Barcelona) ; Fernandez Aviles, Francesc (Hospital Clínic i Provincial de Barcelona) ; Alsina Manrique, Laia (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Cytotoxic T-lymphocyte antigen-4 (CTLA-4) haploinsufficiency is a T-cell hyperactivation disorder that can manifest with both immunodeficiency and immune dysregulation. Approximately one-third of patients may present mild symptoms and remain stable under supportive care. [...]
2022 - 10.3389/fimmu.2022.1070068
Frontiers in immunology, Vol. 13 (december 2022)  
7.
10 p, 582.3 KB Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma / López Corral, Lucia (Complejo Asistencial Universitario de Salamanca. Instituto de Investigación Biomédica de Salamanca) ; Caballero Velazquez, Teresa (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; López-Godino, Oriana (Hospital Universitario Morales Meseguer y Centro Regional de Hemodonación. IMIB. Universidad de Murcia) ; Rosiñol, Laura (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Pérez-Vicente, Sabina (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Fernandez Aviles, Francesc (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Krsnik, Isabel (Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana) ; Morillo, Daniel (Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana) ; Heras, Inmaculada (Hospital Universitario Morales Meseguer y Centro Regional de Hemodonación. IMIB. Universidad de Murcia) ; Morgades, Mireia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rifon, Jose (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ; Sampol, Antonia (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Iniesta, Francisca (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Ocio, Enrique M. (Complejo Asistencial Universitario de Salamanca. Instituto de Investigación Biomédica de Salamanca) ; Martin, Jesús (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Rovira Tarrats, Montserrat (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Cabero, Martín (Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana) ; Castilla-Llorente, Cristina (Hematology Department. Gustave Roussy Cancer Center) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Torres-Juan, Marta (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Moraleda, José María (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ; Martinez, Carmen (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Vázquez, Alejandro (Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana) ; Gutiérrez-García, Gonzalo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Caballero, Dolores (Complejo Asistencial Universitario de Salamanca. Instituto de Investigación Biomédica de Salamanca) ; San-Miguel, J (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ; Mateos, M. V (Complejo Asistencial Universitario de Salamanca. Instituto de Investigación Biomédica de Salamanca) ; Pérez-Simón, José Antonio (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Universitat Autònoma de Barcelona
Multiple myeloma (MM) remains as an incurable disease and, although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative approach, most patients ultimately relapse, and their treatment remains challenging. [...]
2019 - 10.1016/j.bbmt.2019.04.026
Biology of blood and marrow transplantation, Vol. 25 Núm. 9 (september 2019) , p. 1703-1712  
8.
6 p, 378.5 KB Quantitative PCR Is Faster, More Objective, and More Reliable Than Immunohistochemistry for the Diagnosis of Cytomegalovirus Gastrointestinal Disease in Allogeneic Stem Cell Transplantation / Suárez-Lledó, M. (Hospital Clínic i Provincial de Barcelona) ; Marcos, Maria Angeles (Institut de Salut Global de Barcelona) ; Cuatrecasas, Miriam (Hospital Clínic i Provincial de Barcelona) ; Bombi, J. A. (Hospital Clínic i Provincial de Barcelona) ; Fernandez Aviles, Francesc (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Magnano, Laura (Hospital Clínic i Provincial de Barcelona) ; Martínez-Cibrián, N. (Hospital Clínic i Provincial de Barcelona) ; Llobet, N. (Hospital Clínic i Provincial de Barcelona) ; Rosiñol Dachs, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gutiérrez-García, Gonzalo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Jorge, S. (Hospital Clínic i Provincial de Barcelona) ; Martínez Muñoz, Carmen (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rovira Tarrats, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Urbano Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Diagnosis of gastrointestinal (GI) cytomegalovirus (CMV) disease relies on the presence of GI symptoms and detection of CMV, mainly by immunohistochemistry (IHC), in GI biopsy specimens. Thus, in a symptomatic patient, a positive CMV-IHC result is accepted as a diagnosis of CMV disease. [...]
2019 - 10.1016/j.bbmt.2019.07.016
Biology of blood and marrow transplantation, Vol. 25 Núm. 11 (november 2019) , p. 2281-2286  
9.
14 p, 657.9 KB Cardiopoietic cell therapy for advanced ischaemic heart failure : results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial / Bartunek, Jozef (Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis OLV Hospital, Moorselbaan 164, Aalst, B-9300, Aalst, Belgium) ; Terzic, Andre (Mayo Clinic, Center for Regenerative Medicine, Department of Cardiovascular Diseases, 200 First Street SW, Rochester, Minnesota 550905, USA) ; Davison, Beth A. (Momentum Research, Inc, Durham, NC, USA) ; Filippatos, Gerasimos S. (University General Hospital Attikon (Haidari, Grècia)) ; Radovanovic, Slavica (University Hospital Center Bezanijska Kosa, Belgrade, Serbia) ; Beleslin, Branko (University of Belgrade. Cardiology Clinic) ; Merkely, Bela (Semmelweis University. Heart and Vascular Center) ; Musialek, Piotr (Jagiellonian University Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow, Poland) ; Wojakowski, Wojciech (Third Division of Cardiology, Medical University of Silesia, Katowice, Poland) ; Andreka, Peter (Gottsegen Gyorgy Hungarian Institute of Cardiology, Budapest, Hungary) ; Horvath, Ivan G. (Heart Institute, University of Pécs, Pécs, Hungary) ; Katz, Amos (Department of Cardiology, Barzilai Medical Center, Israel Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel) ; Dolatabadi, Dariouch (Division of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium) ; El Nakadi, Badih (Division of Cardiology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium) ; Arandjelovic, Aleksandra (Cardiology Department, Clinical Hospital Zvezdara, Belgrade, Serbia) ; Edes, Istvan (Department of Cardiology, University of Debrecen, Debrecen, Hungary) ; Seferovic, Petar M. (University of Belgrade School of Medicine, Belgrade University Medical Center, Belgrade, Serbia) ; Obradovic, Slobodan (Clinic of Emergency Medicine, Military Medical Academy, School of Medicine, University of Defense, Belgrade, Serbia) ; Vanderheyden, Marc (Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis OLV Hospital, Moorselbaan 164, Aalst, B-9300, Aalst, Belgium) ; Jagic, Nikola (Clinical Center Kragujevac, Kragujevac, Serbia) ; Petrov, Ivo (Department of Cardiology, Angiology, and Electrophysiology, City Clinic Heart and Vascular Institute, Sofia University, Sofia, Bulgaria) ; Atar, Shaul (Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel) ; Halabi, Majdi (Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel) ; Gelev, Valeri L. (Department of Cardiology, Angiology, and Electrophysiology, City Clinic Heart and Vascular Institute, Sofia University, Sofia, Bulgaria) ; Shochat, Michael K. (Heart Institute, Hillel Yaffe Medical Center, Hadera, Rappaport School of Medicine, Haifa, Israel, Technion) ; Kasprzak, Jaroslaw D. (Medical University of Lodz) ; Sanz-Ruiz, Ricardo (Hospital General Universitario Gregorio Marañón) ; Heyndrickx, Guy R. (Cardiovascular Center, Onze-Lieve-Vrouwziekenhuis OLV Hospital, Moorselbaan 164, Aalst, B-9300, Aalst, Belgium) ; Nyolczas, Noémi (Medical Centre, Hungarian Defense Forces, Budapest, Hungary) ; Legrand, Victor (Department of Cardiology, Centre Hospitalier Universitaire de Liège, Liège, Belgium) ; Guédès, Antoine (Department of Cardiology, Universite Catholique de Louvain, CHU UcL Namur, Yvoir, Belgium) ; Heyse, Alex (Department of Cardiology, AZ Glorieux, Ronse, Belgium) ; Moccetti, Tiziano (Cardiocentro Ticino, Lugano, Switzerland) ; Fernandez Aviles, Francesc (Hospital General Universitario Gregorio Marañón) ; Jimenez-Quevedo, Pilar (Hospital Clínico San Carlos (Madrid)) ; Bayés-Genís, Antoni (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hernandez-Garcia, Jose Maria (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Ribichini, Flavio (Department of Cardiology, University of Verona, Italy) ; Gruchala, Marcin (Department of Cardiology, Medical University of Gdansk, Gdansk, Poland) ; Waldman, Scott A. (Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA) ; Teerlink, John R. (School of Medicine, University of California San Francisco and Section of Cardiology, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA) ; Gersh, Bernard J. (Mayo Clinic, Center for Regenerative Medicine, Department of Cardiovascular Diseases, 200 First Street SW, Rochester, Minnesota 550905, USA) ; Povsic, Thomas J. (Duke Clinical Research Institute and Duke Medicine, Durham, NC, USA) ; Henry, Timothy D. (Cedars Sinai Heart Institute (Los Angeles, Estats Units d'Amèrica)) ; Metra, Marco (Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University and Spedali Civili, Brescia, Italy) ; Hajjar, Roger J. (Mount Sinai School of Medicine, New York, NY, USA) ; Tendera, Michal (Third Division of Cardiology, Medical University of Silesia, Katowice, Poland) ; Behfar, Atta (Mayo Clinic, Center for Regenerative Medicine, Department of Cardiovascular Diseases, 200 First Street SW, Rochester, Minnesota 550905, USA) ; Alexandre, Bertrand (Celyad, Mont Saint Guibert, Belgium) ; Seron, Aymeric (Celyad, Mont Saint Guibert, Belgium) ; Stough, Wendy Gattis (Departments of Clinical Research and Pharmacy Practice, Campbell University College of Pharmacy and Health Sciences, Cary, NC, USA) ; Sherman, Warren (Celyad, Mont Saint Guibert, Belgium) ; Cotter, Gad (Momentum Research, Inc, Durham, NC, USA) ; Wijns, William (The Lambe Institute for Translational Medicine and Curam, National University of Ireland Galway and Saolta University Healthcare Group, Galway, Ireland) ; Universitat Autònoma de Barcelona
Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-based biotherapy in a larger heart failure cohort. [...]
2016 - 10.1093/eurheartj/ehw543
European heart journal, Vol. 38 (december 2016) , p. 648-660  

Vea también: autores con nombres similares
4 Fernandez-Aviles, F.
1 Fernandez-Aviles, Francisco
4 Fernandez-Avilés, F.
1 Fernández-Aviles, Francisco
4 Fernández-Avilés, F.
1 Fernández-Avilés, Francisco
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.